Search research articles
Contact Us
Filters
Showing results (241-250 of 289) with videos related to
Page
of 29
Sort By:
Muscle & Nerve
|
January 25, 2019
Revised upper limb module for spinal muscular atrophy: 12 month changes
Maria Carmela Pera, Giorgia Coratti, Elena S Mazzone, et al.
Brain : a Journal of Neurology
|
August 28, 2015
Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene
Oranee Sanmaneechai, Shawna Feely, Steven S Scherer, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 24, 2021
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study
Stacy A Rudnicki, Jinsy A Andrews, Tina Duong, et al.
Plos One
|
April 9, 2013
SMA-MAP: a plasma protein panel for spinal muscular atrophy
Dione T Kobayashi, Jing Shi, Laurie Stephen, et al.
The Lancet. Neurology
|
March 20, 2021
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W Day, Richard S Finkel, Claudia A Chiriboga, et al.
Neurology
|
September 8, 2021
Association Between Body Mass Index and Disability in Children With Charcot-Marie-Tooth Disease
Gabrielle A Donlevy, Sarah P Garnett, Kayla M D Cornett, et al.
Brain : a Journal of Neurology
|
October 22, 2021
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
Michael Benatar, Joanne Wuu, Caroline McHutchison, et al.
Neurology
|
August 1, 2014
Observational study of spinal muscular atrophy type I and implications for clinical trials
Richard S Finkel, Michael P McDermott, Petra Kaufmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 29, 2014
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
V Fridman, B Bundy, M M Reilly, et al.
Journal of Neuromuscular Diseases
|
June 14, 2021
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial
Richard S Finkel, Craig M McDonald, H Lee Sweeney, et al.
Page
of 29
Search research articles
Search
Showing results (241-250 of 289) with videos related to
Sort By:
Page
of 29
Muscle & Nerve
|
January 25, 2019
Revised upper limb module for spinal muscular atrophy: 12 month changes
Maria Carmela Pera, Giorgia Coratti, Elena S Mazzone, et al.
Brain : a Journal of Neurology
|
August 28, 2015
Genotype-phenotype characteristics and baseline natural history of heritable neuropathies caused by mutations in the MPZ gene
Oranee Sanmaneechai, Shawna Feely, Steven S Scherer, et al.
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics
|
February 24, 2021
Reldesemtiv in Patients with Spinal Muscular Atrophy: a Phase 2 Hypothesis-Generating Study
Stacy A Rudnicki, Jinsy A Andrews, Tina Duong, et al.
Plos One
|
April 9, 2013
SMA-MAP: a plasma protein panel for spinal muscular atrophy
Dione T Kobayashi, Jing Shi, Laurie Stephen, et al.
The Lancet. Neurology
|
March 20, 2021
Onasemnogene abeparvovec gene therapy for symptomatic infantile-onset spinal muscular atrophy in patients with two copies of SMN2 (STR1VE): an open-label, single-arm, multicentre, phase 3 trial
John W Day, Richard S Finkel, Claudia A Chiriboga, et al.
Neurology
|
September 8, 2021
Association Between Body Mass Index and Disability in Children With Charcot-Marie-Tooth Disease
Gabrielle A Donlevy, Sarah P Garnett, Kayla M D Cornett, et al.
Brain : a Journal of Neurology
|
October 22, 2021
Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases
Michael Benatar, Joanne Wuu, Caroline McHutchison, et al.
Neurology
|
August 1, 2014
Observational study of spinal muscular atrophy type I and implications for clinical trials
Richard S Finkel, Michael P McDermott, Petra Kaufmann, et al.
Journal of Neurology, Neurosurgery, and Psychiatry
|
November 29, 2014
CMT subtypes and disease burden in patients enrolled in the Inherited Neuropathies Consortium natural history study: a cross-sectional analysis
V Fridman, B Bundy, M M Reilly, et al.
Journal of Neuromuscular Diseases
|
June 14, 2021
A Randomized, Double-Blind, Placebo-Controlled, Global Phase 3 Study of Edasalonexent in Pediatric Patients with Duchenne Muscular Dystrophy: Results of the PolarisDMD Trial
Richard S Finkel, Craig M McDonald, H Lee Sweeney, et al.
Page
of 29